US Patent 9944690 Methods for controlling T cell proliferation
Patent 9944690 was granted and assigned to Bellicum Pharmaceuticals, Inc. on April, 2018 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9944690 Methods for controlling T cell proliferation
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
